Sio Capital Management »

ImmunoGen shares owned by Sio Capital Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 233k 15.87
2023-06-30 $4.6M 246k 18.87
2018-03-31 $2.9M 275k 10.52

More positions owned by Sio Capital Management

Laboratory Corp Amer Hldgs Com New (LH)
Globus Med Cl A (GMED)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Cigna Corp (CI)
Ge Healthcare Technologies I Common Stock (GEHC)
Bicycle Therapeutics Sponsored Ads (BCYC)
Pfizer (PFE)
Organon & Co Common Stock (OGN)
Teleflex Incorporated (TFX)
Regeneron Pharmaceuticals (REGN)
Medtronic SHS (MDT)
Embecta Corp Common Stock (EMBC)
Healthcare Services (HCSG)
Orthofix Medical (OFIX)

View all positions for Sio Capital Management

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen